Viewing Study NCT01740427

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:18 AM
Ignite Modification Date: 2026-02-06 @ 2:19 AM
Study NCT ID: NCT01740427
Status: COMPLETED
Last Update Posted: 2024-11-14
First Post: 2012-11-26
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast cancer View
None postmenopausal women View
None estrogen-receptor positive View
None HER2 negative View
None locoregionally recurrent View
None metastatic View
None Palbociclib (PD-0332991) View
None PALOMA-2 View